Close Menu

asset acquisition

The cell metabolism and bioenergetics technology has been folded into Agilent's Mass Spectrometry Division in the Life Sciences and Applied Markets Group.

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

DDC provides private DNA testing services including biological family relationship testing, veterinary testing, forensic testing, and medical applications including cell-line authentication.

Cancer Genetics said the deal is expected to provide it between $10 million and $12 million in revenues. 

As part of the deal, expected to close on Oct. 9, Cancer Genetics will pay $14 million in cash and stock. 

Oncimmune is repurchasing a CLIA-certified lab that it sold to Health Diagnostic Laboratory in October 2013.

True Health will pay $37.1 million to acquire substantially all the assets of Health Diagnostic Laboratory, which is currently in Chapter 11 reorganization. 

Sengenics is rebranding the technology Immunome and expects it to expand the company's footprint in the proteomics space.

Illumina has not yet disclosed the price it paid for the Canadian laboratory information management systems software developer.

Roche is buying Lumora's heat elution technology, which enables nucleic acid isolation in minutes, as opposed to hours. 

Pages

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.